ASP8825 - Study in Patients With Restless Legs Syndrome

Status Completed

Clinical Trial Summary

To demonstrate the superiority of ASP8825 over placebo and the dose response in patients with restless legs syndrome

Clinical Trial Description

Three doses of ASP8825 are compared to placebo in efficacy and safety point of view in patients with restless legs syndrome ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00530530
Study type	Interventional
Source	Astellas Pharma Inc
Contact
Status	Completed
Phase	Phase 2
Start date	September 2007
Completion date	January 2009

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04786314` - The Effect of Hot and Cold Water Application on Pregnant Women With Restless Leg Syndrome	N/A
Completed	`NCT01455012` - Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome	Phase 4
Terminated	`NCT01192503` - Safety and Efficacy of Rasagiline in Restless Legs Syndrome	Phase 2/Phase 3
Completed	`NCT00721279` - Sifrol (Pramipexole) Onset of Action and Impact: a 12-weeks Observational Study in Patients With Primary Restless Legs Syndrome	N/A
Completed	`NCT00942253` - Exercise Training in Dialysis Patients With Restless Legs Syndrome (RLS)	Phase 2
Completed	`NCT00375284` - A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS	Phase 4
Completed	`NCT00479531` - Sequential Compression Devices for Treatment of Restless Legs Syndrome	Phase 3
Recruiting	`NCT05581576` - Pitolisant in Refractory Restless Legs Syndrome	Phase 4
Active, not recruiting	`NCT03218969` - Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist	Phase 1/Phase 2
Recruiting	`NCT04144790` - Impact of Iron Supplementation Treatment on Brain Iron Concentrations
Completed	`NCT05787080` - Massage, Oxidative and Antioxidant Enzymes in Hemodialysis Patients With Restless Legs Syndrome(RLS)	N/A
Not yet recruiting	`NCT05529095` - Sublingual Apomorphine in Refractory Restless Legs Syndrome	Phase 4
Recruiting	`NCT05044520` - Clinical Features Associated With Restless Legs Syndrome.
Withdrawn	`NCT03849001` - Impact of Acute Leg Cycling at Various Intensities on RLS Severity in Persons With MS	N/A
Completed	`NCT03076541` - Cardiovascular Variability, Heart Rate Response, and Electromyogram Power Associated With Periodic Leg Movements.	N/A
Recruiting	`NCT04145674` - A Proof of Concept, Phase 2, Double-blind, Randomized Trial With d-Methadone Product Versus Placebo	Phase 2
Completed	`NCT02532608` - Infra-slow Oscillations During Sleep	N/A
Completed	`NCT01528462` - Sleep Disorders Managed and Assessed Rapidly in Transient Ischemic Attack (TIA) and In Early Stroke
Completed	`NCT00748098` - Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Disturbance	Phase 3
Completed	`NCT00373542` - 12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome	Phase 4